ArticleCardiovascular diabetology. Endocrinology reports2026
The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis.
Kezia Peter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.